The National Apartment Association taps Invariant to help lobby on housing affordability and supply, consumer reporting and fair housing policy, according to the filing.
A lawmaker intends to give the FDA better tools to ensure confirmatory research needed to complete accelerated drug approvals. But he is already encountering opposition.
The House Energy and Commerce’s health panel reviewed nearly two dozen bills Thursday that might be candidates for inclusion as riders in an FDA user fee reauthorization package later this year.
Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation.